3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Neoplasms
4
Colorectal Neoplasms
4
Head and Neck Neoplasms
2
Diabetes Mellitus
2
Chronic Disease
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Sleep Wake Disorders
1
Sleep Initiation and Maintenance Disorders
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Multiple Myeloma
1
Mucositis
1
Motor Activity
1
Lymphoma
1
Lymphoid Interstitial Pneumonia
1
Lymphedema
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hypertension
1
Coronary Disease
1
Cardiovascular Diseases
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
30
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
20
Papillomavirus Vaccines
9
Radiotherapy, Intensity-Modulated
4
Cisplatin
4
Blood Specimen Collection
4
fludarabine
3
Vaccines, Synthetic
3
Engerix-B
3
Cyclophosphamide
3
halofantrine
2
fludarabine phosphate
2
aldesleukin
2
Watchful Waiting
2
Vaccines
2
Patient Navigation
2
Paclitaxel
2
Light Coagulation
2
Interleukin-2
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine nonavalent
2
Hepatitis A Vaccines
2
Fluorouracil
2
Electrocoagulation
2
Cetuximab
2
Carboplatin
2
Albumin-Bound Paclitaxel
2
utomilumab
1
polyphenon E
1
infigratinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Papillomavirus Infections
×
Methods
×
Clear all
No trials found.